Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2026-01-04 @ 12:13 AM
Study NCT ID:
NCT05134532
Status:
UNKNOWN
Last Update Posted:
2023-04-26
First Post:
2021-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC
Sponsor:
CHA University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2021-05-048-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |